The United Natural Products Alliance has signed a Memorandum of Understanding (MOU) with the University of Arkansas for Medical Sciences, allowing industry stakeholders access to the medical school’s analytical, technical and policy expertise.
A cannabidiol (CBD) manufacturer is calling for greater regulatory controls after independent analyses of 31 CBD-based products found varying levels of active ingredients as well as CBD-related labelling issues.
With 332% growth year-on-year and $52 million in sales, cannabidiol (CBD) has taken the top spot as the best-selling herbal supplement in the natural channel, according to the 2018 HerbalGram Herb Market Report by the American Botanical Council.
Senate Majority Leader Mitch McConnell has introduced language into a congressional spending report that would require the FDA to issue formal enforcement discretion on the sale of hemp-derived CBD products within 120 days, clearing a path for the lawful...
Medical Marijuana Inc, despite its name one of the early players in the hemp/CBD supplement field, has announced sales increases topping 30% and a move to develop products based on additional cannabinoids.